Forte Biosciences (FBRX) Profit After Tax (2016 - 2020)
Historic Profit After Tax for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$10.3 million.
- Forte Biosciences' Profit After Tax rose 3982.67% to -$10.3 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$56.7 million, marking a year-over-year decrease of 668.37%. This contributed to the annual value of -$63.5 million for FY2019, which is 2974.36% down from last year.
- As of Q1 2020, Forte Biosciences' Profit After Tax stood at -$10.3 million, which was up 3982.67% from -$10.6 million recorded in Q4 2019.
- In the past 5 years, Forte Biosciences' Profit After Tax registered a high of -$383000.0 during Q3 2018, and its lowest value of -$19.6 million during Q4 2018.
- Its 5-year average for Profit After Tax is -$11.5 million, with a median of -$10.3 million in 2020.
- Per our database at Business Quant, Forte Biosciences' Profit After Tax surged by 9615.19% in 2018 and then crashed by 479164.49% in 2019.
- Quarter analysis of 5 years shows Forte Biosciences' Profit After Tax stood at -$8.4 million in 2016, then fell by 28.55% to -$10.8 million in 2017, then crashed by 80.89% to -$19.6 million in 2018, then soared by 46.01% to -$10.6 million in 2019, then grew by 2.86% to -$10.3 million in 2020.
- Its Profit After Tax was -$10.3 million in Q1 2020, compared to -$10.6 million in Q4 2019 and -$18.7 million in Q3 2019.